Nitrous Oxide Inhalant Product

Phase 1Small molecule

UUniversity of Manitoba

Nitrous Oxide Inhalant Product is one of 3 small molecule programs targeting Nitrous Oxide. It is currently in Phase 1.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Nitrous OxideRecruiting

Nitrous OxidePhase 1

Recruiting

Competition

Competitive Landscape

3 competitors in Nitrous Oxide

#DrugCompanyPhaseTrials

Local Anesthetic

RRennes University Hospital

Preclinical

1 2

Nitrous Oxide Inhalant Product

UUniversity of Manitoba

Phase 1

1 3

Local Anesthetics,topical

FFederal University of Minas Gerais

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q4 2027

Phase 1Recruiting

Nitrous Oxide

NCT03695887

Clinical

Trials by Indication[1]

Nitrous Oxide1 trial

A Pilot Trial of Disposable Nitrous Oxide Canisters in Providing Pain Control During Burn Dressing Changes

Recruiting·UUniversity of Manitoba·Phase 1·NCT03695887·30 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Nitrous Oxide Inhalant Product. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Nitrous Oxide Inhalant Product compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Nitrous Oxide Inhalant Product. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — University of Manitoba company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 1[1]
Company: UUniversity of Manitoba

Nitrous Oxide Inhalant Product

Status by Indication[3][1]

Competitive Landscape

Expected Milestones

Q4 2027

Trials by Indication[1]

Nitrous Oxide1 trial

References

Drug Info

Quick Facts

Related News